NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 212

Retail Sleep History Medicine 212

Veriheal

APRIL 23, 2024

Cannabis use is increasing all around the world. These surveys explore the motivations and methods behind cannabis usage for both medical purposes and recreational enjoyment. In this piece, we aim to delve into the use of cannabis among Generation Z (those born between 1997 and 2012) for purposes of happiness, healing, and relief.

Chronic Pain 108

Chronic Pain Data Edibles Sleep 108

CannaMD

NOVEMBER 4, 2020

Cannabis has been used for centuries to manage chronic pain from all sources and, as a recent study highlights, its positive effects extend to migraines. and Canada to measure medical marijuana use among migraine patients and its effectiveness as a migraine treatment. 30 percent of migraine patients in the U.S. The results?

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

SpeedWeed

APRIL 10, 2021

Chronic pain patients who used cannabis saw sustained improvement in their condition over time, according to the results of a recently released study. The data revealed a sustained improvement in the participants’ symptoms. The data revealed a sustained improvement in the participants’ symptoms. View original article.

Chronic Pain 52

Chronic Pain Patients Treatment Data 52

Project CBD

MARCH 21, 2023

For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

United Patients Group

MAY 17, 2023

Cannabinoids can promote sleep by activating receptors in the brain called endocannabinoid receptors CB1R and CB2R that regulate sleep cycles, pain perception, immune responses and moods such as depression. They can also promote sleep by activating receptors in the brain that regulate circadian rhythm (the biological clock).

Sleep 78

Sleep Cannabinoids Patients CBD 78

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Veriheal

MAY 18, 2023

annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. Chronic pain —a condition that affects 50.2

Chronic Pain 89

Chronic Pain Treatment Research and Development Patients 89

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). Researchers Analyzed Survey Results from 280 Epilepsy Patients.

Epilepsy 58

Epilepsy Pharmaceutical Patients Sleep 58

Veriheal

NOVEMBER 21, 2023

Veriheal remains dedicated to supporting the next generation of pioneers through its Innovation in Cannabis Scholarship. This year, we are proud to continue our investment in the next generation of cannabis industry leaders. Their one-of-a-kind innovations and solutions are invaluable to the future of cannabis.

Research and Development 93

Research and Development Consumption Education Data 93

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Less well-known symptoms include sleep disorders , cognitive changes, pain, anxiety, depression , and hallucinations. One such alternative treatment is cannabis.

Patients 52

Patients Treatment Therapy Sleep 52

LifeCannMD

JANUARY 2, 2024

Here’s a breakdown of how cannabis might help those with Florida qualifying conditions : Florida Cancer Patients : Patients say that it benefits them in several ways: by quelling nausea, suppressing vomiting resulting from chemotherapy, increasing appetite, alleviating pain, and soothing anxiety.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

MedicalJane

JUNE 12, 2020

A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? Also, a recent systematic review of healthcare professionals’ “cannabis knowledge” reported “there was a unanimous lack of self-perceived knowledge surrounding all aspects of medicinal cannabis” (2). million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Medical Marijuana 411

MAY 10, 2022

The post Cornell University study shows a decline in prescription medicines in US states with legal adult-use cannabis appeared first on Medical Marijuana 411.

Medicine 59

Medicine Legalization Sleep Data 59

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. As the disease progresses, individuals may suffer from loss of memory and dementia.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Cannabis Law Report

JULY 23, 2021

SAN MARCOS — Parallel , one of the largest cannabis companies in the country, selected San Marcos as home to its new $25 million Texas headquarters for the medical cannabis company, goodblends. According to a New Frontier Data Report, the overall legal cannabis industry in America is valued at roughly $13.2

Tincture 105

Tincture Patients Sleep Retail 105

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Veriheal

AUGUST 15, 2022

Cannabis, a plant wrongly accused of causing laziness and tiredness in consumers, could actually offer fatigue-fighting benefits. This is according to a group of researchers from the University of New Mexico (UNM) , who recently teamed up with the creators of the Releaf App to investigate the true link between cannabis use and energy levels.

Treatment 80

Treatment Research and Development Sativa Cannabinoids 80

SpeedWeed

AUGUST 22, 2021

A report released by the MS Society states that not nearly enough medical cannabis patients have been able to obtain medical cannabis through the National Health Service (NHS), despite research and firsthand accounts of its effectiveness as a medicine for MS patients. I didn’t realize how tough it was until it stopped.”.

Sleep 52

Sleep Access Patients Treatment 52

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

The Cannigma

MARCH 2, 2021

Many US military veterans avoid speaking to a doctor before self-medicating with cannabis due to stigma and fear of consequences, potentially putting their health at risk, according to the findings of a new study. Reddit and the anonymity to talk about cannabis. What are veterans using medical cannabis for? Shutterstock).

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

TheAnswerPage

AUGUST 3, 2021

Does THC have a dose-dependent effect on sleep? Yes – Human experimental data suggests “THC has a dose-dependent effect on sleep—low doses appear to decrease sleep onset latency and increase slow-wave sleep and total sleep time, while high doses appear to cause sleep disturbances.”

Sleep 59

Sleep Data THC Cannabinoids 59

Veriheal

JANUARY 26, 2023

According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar disorder. In this article, we’ll explore how the potential advantages of cannabis might help stabilize symptoms associated with bipolar disorder.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

The Joint Blog

DECEMBER 12, 2019

The research was published in the journal PLOS One – the name of the study is Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. For the study researchers “included data from people in 2 prospective cohorts. Methods and findings.

Chronic Pain 49

Chronic Pain Patients Data Sleep 49

Cannabis Law Report

AUGUST 24, 2022

Here’s what they say – nothing that any cannabis user hasn’t know since the 19080’s ! Results from the third Cannabis as Medicine study. The third Cannabis as Medicine Survey (CAMS20) follows on from CAMS16 and CAMS18, and includes 1,600 people using medical cannabis between September 2020 and January 2021.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

CannaMD

JULY 23, 2020

In fact, a new study published in the Yale Journal of Biology and Medicine found that cannabis flower may provide near-immediate relief of depression symptoms! Cannabis users reported feeling relaxed, peaceful, happy and optimistic, and when measured on a quantitative scale of 0 to 10, users reported an average of a 3.76-point

Data 89

Data Chronic Pain Sleep Patients 89

Project CBD

JANUARY 24, 2019

Some recent highlights and curiosities from the amazing world of cannabis science and therapeutics: CBD and autism. In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Cannabis and ADHD.

Research and Development 252

Research and Development Chronic Pain Cannabinoids Treatment 252

The Cannigma

FEBRUARY 1, 2021

The main active chemical in cannabis, tetrahydrocannabinol (THC), may have a negative impact on short-term memory. Some research even points to memory issues and changes to the brain for longer-term cannabis users. How cannabis interacts with memory. gpointstudio/123rf).

Terpenes 127

Terpenes THC Cannabinoids CBD 127

The Cannigma

MARCH 14, 2023

During the height of cannabis prohibition, admitting consumption was very risky. Not only was the identity of “cannabis consumer” tied to stereotypes such as laziness , lack of success and ambition and “a motivational syndrome”, it could result in incarceration and the strict collateral sanctions associated with a drug charge.

Policy 96

Policy Research and Development Conditions Consumption 96

FloridaMarijuana.net

SEPTEMBER 24, 2018

Just like all other plants, the Cannabis plant produces and excretes beneficial essential oils. These essential oils are called Terpenes, and while research is still evolving, science has proven that these oils can drastically improve a patient’s quality of life. Over 100 cannabis-based Terpenes have been discovered.

Terpenes 162

Terpenes Oil Strains Research and Development 162

The Joint Blog

MARCH 18, 2021

According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS). Additional information on cannabis and PTSD is available from NORML.

Cannabinoids 26

Cannabinoids Patients Clinical Trials Research and Development 26

The Joint Blog

JANUARY 21, 2020

Marijuana use is associated with subjective benefits in patients with Tourette Syndrome (TS), according to a new study published in the journal Cannabis and Cannabinoid Research. The study is titled Treatment of Gilles de la Tourette Syndrome in cannabis-based medicine: Results from a retrospective analysis and online survey.

Patients 29

Patients Marijuana Data Treatment 29

Cannabis Law Report

FEBRUARY 2, 2022

UK website Leafie writes… The findings of a study published in JAMA Psychiatry have revealed that road testing for cannabis impairment may be putting up to 1.4m medical cannabis users at risk of unfair prosecution, according to a report by Volteface. Further simulator tests were given at 30 minutes, 1.5, hours after smoking.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52